METHODOLOGY

ARTISTIC COMPONENTS:

• In-silico viral design (TERT + Replication competent plasmid)
• Deployment planning using interactive viral transmission models
• Viral deployment advertising campaign to generate volunteers
• Staged release through influencer infection

KEY QUESTIONS:

• Does life extension require consent?
• Is withholding life-extending technology equivalent to denying medical care?
• What happens to social structures when death becomes optional?
• How might states respond to unauthorized life extension?